StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IRIX

IRIDEX Corporation

IRIX Nasdaq Electromedical & Electrotherapeutic Apparatus EDGAR ↗
$0.83
-0.01 -0.60%

Key statistics

from XBRL data in SEC filings
Market cap
$14.4M
Revenue (TTM)
$52.6M
Net income (TTM)
-$3.27M
EPS (TTM)
$-0.19
P/E ratio
Dividend yield
Free cash flow
-$2.26M
Cash
$4.59M
Total assets
$28.3M
Gross margin
36.0%
52-week range
$0.80 – $1.65

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results; Regulation FD disclosure Jul 16, 2026 8-K Other events Jun 18, 2026 10-Q Quarter ended 2026-04-04 May 19, 2026 8-K Results of operations (earnings release) May 19, 2026 10-K Fiscal year ended 2026-01-03 Apr 2, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Entered a material agreement; Took on a direct financial obligation Mar 13, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Regulation FD disclosure Dec 11, 2025 10-Q Quarter ended 2025-09-27 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Sep 9, 2025 10-Q Quarter ended 2025-06-28 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 13, 2025 8-K Entered a material agreement May 22, 2025 8-K Delisting notice or listing-rule failure May 20, 2025 10-Q Quarter ended 2025-03-29 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Results of operations (earnings release) Apr 14, 2025 8-K Director or officer change Apr 8, 2025 8-K Director or officer change Apr 3, 2025 10-K Fiscal year ended 2024-12-28 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Other events Mar 20, 2025 8-K Results of operations (earnings release) Jan 14, 2025 8-K/A Director or officer change Nov 26, 2024 8-K Director or officer change Nov 26, 2024 8-K Director or officer change; Other events Nov 13, 2024 10-Q Quarter ended 2024-09-28 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change Oct 3, 2024 8-K Other events Sep 6, 2024 10-Q Quarter ended 2024-06-29 Aug 8, 2024 8-K Results of operations (earnings release); Other events Aug 8, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 5, 2024 8-K Delisting notice or listing-rule failure Jul 3, 2024 8-K Director or officer change; Shareholder vote results Jun 21, 2024 8-K Director or officer change May 24, 2024 10-Q Quarter ended 2024-03-30 May 14, 2024